Dexcom (Nasdaq:DXCM) shares took a hit after hours today on third-quarter results that came in ahead of the consensus forecast. Shares of DXCM fell more than 8% to $62.69 apiece after the market closed today. The San Diego-based continuous glucose monitor (CGM) maker reported profits of $283.8 million. That equals 70¢ per share on sales […]
Dexcom
Dexcom adds Stanford Medicine chair to its board of directors
Dexcom (Nasdaq:DXCM) announced today that it appointed Dr. Euan Ashley to its board of directors, effective Oct. 24, 2025. Ashley, a renowned researcher, entrepreneur and clinician, brings extensive leadership experience across healthcare research institutions and private organizations. He currently serves as chair of the Dept. of Medicine at Stanford Health. Research areas for Ashley span […]
Dexcom is facing a class action suit related to G7 CGM
A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of California. The lawsuit, led by plaintiff Kelly Grisoli on behalf of all others similarly situated, demands a jury trial for claims that Dexcom’s representations for its latest-generation G7 continuous glucose monitor (CGM) were false, misleading, […]
Dexcom CEO takes temporary leave of absence
Dexcom (Nasdaq:DXCM) today filed an SEC form to announce that Chair and CEO Kevin Sayer is taking a temporary medical leave of absence. Sayer’s leave went into effect on Sept. 14, 2025. The Dexcom board appointed Jake Leach to serve as interim principal executive officer, in addition to his current duties as president and COO. Leach […]
Dexcom to unveil new basal insulin titration module under FDA review, reports positive CGM data
Dexcom (Nasdaq:DXCM) today announced plans to unveil its Smart Basal integrated titration module for insulin delivery. The company plans to unveil Smart Basal and present new continuous glucose monitor (CGM) data at the 61st annual European Association for the Study of Diabetes (EASD) Conference in Vienna, Austria, this week. Dexcom’s CTO Girish Naganathan will speak […]
FDA identifies serious recall for Dexcom CGM mobile apps
The FDA identified a recent recall of smartphone apps for Dexcom (Nasdaq:DXCM) continuous glucose monitors (CGMs) as the most serious type. This recall involves correcting certain devices through a software update. It does not involve removing them from where they are used or sold. Serious recalls can lead to serious injury or death without correction. […]
Court dismisses several claims against Dexcom in securities lawsuit
A California judge has dismissed several claims against Dexcom (Nasdaq:DXCM) officials related to alleged misrepresentation of sales efforts. Judge Robert S. Huie of the Southern District of California ruled in the consolidated action, which combines three securities class actions against the San Diego-based continuous glucose monitor (CGM) maker. Huie’s judgment denied Dexcom’s motion to dismiss […]
The top Dexcom stories of 2025 so far
At Dexcom (Nasdaq:DXCM), one of the leaders in continuous glucose monitoring (CGM), innovation continues to roll on. The company has been expanding its offerings with next-generation sensors, over-the-counter offerings and improved wear times. It has also introduced new AI features and enhanced connectivity that make diabetes management easier. Dexcom’s CTO Girish Naganathan will speak about the future […]
Dexcom to lay off more than 300 employees in California
Dexcom (Nasdaq:DXCM) filed with the state of California to confirm plans to lay off more than 300 employees in San Diego. The leading continuous glucose monitor (CGM) maker filed a Worker Adjustment and Retraining Notification (WARN) notice in California on Aug. 27. California officials processed the filing on Aug. 28 and the headcount cut goes […]
FriskAI, Dexcom to integrate CGM data into AI management platform
FriskAi announced today that it entered into an agreement with Dexcom to integrate data into its AI-powered healthcare platform. The deal enables the integration of G7 and G6 continuous glucose monitor (CGM) data into the FriskAI platform. Arlington, Virginia-based FriskAi designed its platform to support physicians and patients with actionable personalized care management programs. FriskAI’s […]
